Partner Content Partner Content Insightful Developments and an Exclusive Interview from Roch... Ophthalmic Drugs 2018
Partner Content Partner Content Exclusive Interview Released from Santen for Ophthalmic Drug... Exclusive Interview Released from Santen
Partner Content Partner Content Europe’s Leading Ophthalmic Conference is Just 1 week away Ophthalmic Drugs
Partner Content Partner Content SMi’s Europe’s Leading Ophthalmic Conference is only 2 weeks... Ophthalmic Drugs
Partner Content Partner Content SMi’s Ophthalmic Drugs Conference is only 4 weeks away! Only 4 Weeks Remain for Ophthalmic Drugs
Partner Content Partner Content Exceptional speaker line-up for Ophthalmic Drugs Hear from Santen, Novaliq GmBh, Aptar Pharma and more
News AbbVie builds the case for ovarian cancer drug Elahere AbbVie hopes for another lift to its fast-growing ovarian cancer drug Elahere with new survival data.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl